IP Library Granted Patent US 9,347,097
Granted Patent B2
US 9,347,097 · App. 14/220,736 · Granted May 24, 2016

Arrangement for determining the concentration of nucleic acids

Inventors: Walter Gumbrecht (Herzogenaurach, DE); Jörn Mosner (Erlangen, DE); Sebastian Schmidt (Weisendorf, DE)
Assignee: Boehringer Ingelheim Vetmedica GmbH
C12Q1/686B01L3/5027C12Q1/6851B01L7/52B01L2200/143B01L2200/16B01L2300/0645B01L2300/0816B01L2300/0867B01L2300/1822B01L2400/0487B01L2400/0633
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,347,097
App. No.
14/220,736
Granted
May 24, 2016
Kind
B2
Abstract

An arrangement for determining the concentration of nucleic acids in a sample in a microfluidic device. In at least one embodiment, the arrangement having a) a first chamber into which a the sample is introduced, b) an element in the first chamber for carrying out a number of cycles of an amplification reaction to be carried out in cycles for amplifying nucleic acids, c) a second chamber, connectable to the first chamber by way of fluidic communication, equipped with an element to determine concentrations of amplified nucleic acids, d) a control unit to introduce a defined volume of a solution containing reagents for the amplification reaction into the first chamber and to transfer a defined volume from said first chamber to the second chamber.

Claims (26)

1. An arrangement, comprising:

a microfluidic device including,

a first chamber with an element for amplifying nucleic acids by means of an amplification reaction to be carried out in cycles,

a second chamber, connectable to the first chamber by way of fluidic communication, equipped with an element to determine concentrations of amplified nucleic acids, and

at least one valve for interrupting and/or releasing fluidic communication between the chambers;

a single pump to transfer nucleic acids; and

a control unit to control the at least one valve and the pump, and to introduce a defined volume of a solution containing reagents for the amplification reaction into the first chamber and to transfer a defined volume from said first chamber to the second chamber, wherein said control unit is connected to the second chamber, said pump and said at least one valve and being responsive to a signal transmitted from said element of the second chamber to said control unit for operating said pump and/or said at least one valve based on the concentration of amplified nucleic acids determined by said element.

2. The arrangement as claimed in claim 1 , wherein the element of the second chamber to determine the concentration includes a microarray having position-specifically immobilized capture oligonucleotides for detecting the amplified nucleic acids.

3. The arrangement as claimed in claim 1 , further comprising at least one electrochemical detection element configured for measuring at least one of currents and potentials.

4. The arrangement as claimed in claim 1 , further comprising one of a heating and a cooling device configured for amplifying nucleic acids by way of an amplification reaction to be carried out in cycles.

5. The arrangement as claimed in claim 4 , wherein the control unit is further designed for providing a temperature profile for the at least one of a heating and cooling device for the first chamber.

6. The arrangement as claimed in claim 1 , further comprising a computer to calculate the concentration of a nucleic acid in a sample on the basis of a signal of the element of the second chamber to determine the concentration.

7. The arrangement as claimed in claim 1 , further comprising at least one reservoir of reagents for determining the concentration of nucleic acids, the reservoir being connectable to the second chamber by way of fluidic communication.

8. The arrangement as claimed in claim 7 , wherein the reservoir comprises an enzyme label.

9. The arrangement as claimed in claim 7 , wherein the reservoir comprises an enzyme substrate.

10. An arrangement, comprising:

a microfluidic device in form of a cartridge including,

a first chamber with an element for amplifying nucleic acids of a sample by means of an amplification reaction to be carried out in cycles,

a second chamber, connectable to the first chamber by way of fluidic communication, equipped with an element to determine concentrations of amplified nucleic acids, the concentration of the amplified nucleic acids are determined using an enzymatic label,

wherein the element of the second chamber is configured for determining the concentrations of the amplified nucleic acids based on an electrochemical signal generated by an enzymatic reaction catalyzed by the enzymatic label,

a channel through which the sample is introduced into the first chamber, and

at least one valve for interrupting and/or releasing fluidic communication between the chambers,

wherein the first chamber contains reagents in dry form carrying out the amplification reaction;

a single pump to transfer nucleic acids; and

a control unit to control the valve and the pump, and to introduce a defined volume of a solution containing reagents for the amplification reaction into the first chamber and to transfer a defined volume from said first chamber to the second chamber,

wherein the arrangement is configured to transfer defined volumes of amplified nucleic acids subsequently to the second chamber based on the electrochemical signal.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2014
From: SIEMENS AG
To: BOEHRINGER INGELHEIM VETMEDICA GMBH
Reel/Frame 033124/0587 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2014
From: GUMBRECHT, WALTER; MOSNER, JORN; SCHMIDT, SEBASTIAN
To: SIEMENS AKTIENGESELLSCHAFT
Reel/Frame 032809/0080 →
Priority Claims (1)
DE 10 2006 027675 · Jun 14, 2006 · national
Continuity (2)
Division 11808835 · Jun 13, 2007
Related Publication 20140206578A1 · Jul 24, 2014